Different etiologies and prognoses of optic neuritis in demyelinating diseases
Tetsuya Akaishi(Tohoku University Hospital), Kazuo Fujihara(Tohoku University), Toru Nakazawa(Tohoku University), Toshiyuki Takahashi(Fukushima Medical University), Takayuki Takeshita(Tohoku University), Ichiro Nakashima(Tohoku University), Kimihiko Kaneko(Fukushima Medical University), Masashi Aoki(Tohoku University), Douglas Kazutoshi Sato(Fukushima Medical University), Shunji Mugikura(Tohoku University)
Cited by 70
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
|Neurology Neuroimmunology & Neuroinflammation|2017|432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
|Journal of Neurology Neurosurgery & Psychiatry|2018|199
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1
|Journal of Neurology Neurosurgery & Psychiatry|2015|141
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
|Journal of Neurology Neurosurgery & Psychiatry|2016|108